Cita APA

Romero, O. A., Vilarrubi, A., Alburquerque-Bejar, J. J., Gomez Moruno, A., Andrades, A., Trastulli, D., & Oaknin Benzaquen, A. M. (2021). SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.

Citación estilo Chicago

Romero, Octavio A., Andrea Vilarrubi, Juan J. Alburquerque-Bejar, Antonio Gomez Moruno, Alvaro Andrades, Deborah Trastulli, y Ana Mazaltob Oaknin Benzaquen. SMARCA4 Deficient Tumours Are Vulnerable to KDM6A/UTX and KDM6B/JMJD3 Blockade. 2021.

Cita MLA

Romero, Octavio A., et al. SMARCA4 Deficient Tumours Are Vulnerable to KDM6A/UTX and KDM6B/JMJD3 Blockade. 2021.